Thales — M&A Activity 2010

Aug 9, 2010

Press release

CMT MEDICAL TECHNOLOGIES LTD. COMPLETES MERGER TRANSACTION

Yoqneam (Israel), August 9, 2010 - CMT Medical Technologies Ltd. ("CMT") (ENXTPA: CMD) announced today that it has completed its merger transaction with CTH Acquisition Company Ltd. ("CTH"), an Israeli company wholly-owned by Thales, a société anonyme organized and existing under the laws of France ("Thales"), pursuant to which CTH merged with and into CMT. CMT remained the surviving company in the merger and became a wholly-owned subsidiary of Thales. On August 8, 2010, the Israeli Companies Registrar issued a merger certificate evidencing the merger.

Under the terms of the merger agreement, each of the CMT shares outstanding immediately prior to the effective time of the merger (other than shares already held by Thales or CMT or any other wholly-owned subsidiary of Thales or CMT) was automatically converted into, and represent solely, the right to receive from Thales an amount of € 7.10 per share in cash.

As a result of the effective consummation of the merger, Nyse Euronext Paris announced that the CMT shares would be delisted from Euronext Paris before the opening of the trading session today.

Euroclear France will consequently close the code ISIN IL0010832298 for the CMT shares in addition to members' accounts after the closing of the trading session on August 12, 2010. Euroclear France will send balance certifications ("attestations de solde") to intermediaries on August 13, 2010.

By August 31, 2010, at the latest, intermediaries will need to request from Oddo Corporate Finance, Middle Office - Sébastien COURAT, 12 boulevard de la Madeleine, 75009 Paris (Fax: + 33 1 44 51 86 50 - scourat@oddo.fr) the amount of the merger consideration on the basis of the balance certifications, and will then credit the accounts of CMT shareholders with the amount of the merger consideration to which they are entitled to.

Oddo & Cie will proceed with the payment to intermediaries on the basis of balance certifications within 3 trading days of August 31, 2010. Unclaimed amounts will be kept for the benefit of CMT shareholders as may be required by applicable laws.

Further information may be obtained by directing a request via mail, phone, fax or e-mail to Ms. Nadine Tomaschoff, CMT's CFO, at the CMT's offices at HaCarmel Street, Building 7/2 Yoqneam Ilit P.O.B. 111, Israel 20692, Facsimile No. +972-4-856-6298, Tel No. +972-4-856-6220, email: Nadine@cmt.co.il.

About CMT Medical Technologies Ltd.:

CMT Medical Technologies Ltd. is an Israeli company which designs, develops, manufactures and markets digital image processing systems for use in medical diagnostic imaging applications. CMT is also engaged in the development of X-ray detectors for various medical applications.

If you wish to receive further information by e-mail, please contact: Mrs. Nadine Tomaschoff - CFO & Investor Relations at: nadine@cmt.co.il or +972 48 566 225